Ledger.Open graph →
SEC Form D · Amendment · filed November 23, 2020

Kiniksa Pharmaceuticals, Ltd

Offering
$8.8M
Sold
$8.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HAMILTON, Bermuda
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Richard S. Levy · HAMILTON, BermudaDirectorFelix J. Baker · HAMILTON, BermudaDirectorStephen R. Biggar · HAMILTON, BermudaDirectorSanj K. Patel · HAMILTON, BermudaExec · DirectorThomas R. Malley · HAMILTON, BermudaDirectorTracey L. Mccain · HAMILTON, BermudaDirectorKimberly J. Popovits · HAMILTON, BermudaDirectorBarry D. Quart · HAMILTON, BermudaDirectorChristopher P. Mundy · NEW YORK, NYDirectorEric Kanagy · Brooklyn, NYDirectorAlex Brickner · Brooklyn, NYDirectorDominic Napolitano · Darien, CTDirectorSam P. Johnson · NEW YORK, NYDirectorUpper90 Capital Management LP · New York, NYDirectorAndrea Fellows · NEW YORK, NYExec · DirectorBarry D. Quart · HAMILTON, BermudaDirectorThomas W. Beetham · HAMILTON, BermudaExecG. Bradly D. Cole · HAMILTON, BermudaDirectorRick K. Briggs · Old Bridge, NJExec · DirectorSteven L. Shea · Old Bridge, NJDirectorGary P. Scharmett · Old Bridge, NJDirectorStephen K. Necessary · Old Bridge, NJDirectorCharles E. Dietz · Old Bridge, NJDirectorAnthony R. Bruno · Old Bridge, NJDirectorEric R. Skolnik · Old Bridge, NJDirectorEdward R. Grauch · Old Bridge, NJDirectorThomas W. Beetham · HAMILTON, BermudaExecG. Bradly D. Cole · HAMILTON, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗